Hideaki Nakajima Selected Research

Relapsing Polychondritis

1/2022	Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
11/2021	Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
1/2021	Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Nakajima Research Topics

Disease

14	Spinal Cord Injuries (Spinal Cord Injury) 01/2019 - 04/2007
11	Neoplasms (Cancer) 01/2022 - 12/2005
10	Pain (Aches) 01/2022 - 02/2005
9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 06/2002
8	Leukemia 02/2019 - 02/2003
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 11/2016
6	Infections 08/2022 - 09/2009
6	Inflammation (Inflammations) 01/2022 - 01/2016
6	Spinal Cord Diseases 01/2022 - 08/2007
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2022 - 02/2012
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2022 - 09/2015
5	Neuralgia (Stump Neuralgia) 01/2022 - 09/2014
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2022 - 06/2002
4	Pathologic Constriction (Stenosis) 01/2022 - 01/2009
4	Rheumatoid Arthritis 01/2022 - 11/2009
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021 - 01/2015
4	Spinal Cord Compression 10/2019 - 07/2004
4	Osteoarthritis 07/2019 - 02/2012
4	Proteinuria 01/2009 - 05/2002
3	Ulcer 10/2022 - 10/2016
3	Thrombocytopenia (Thrombopenia) 08/2022 - 01/2016
3	Edema (Dropsy) 08/2022 - 01/2009
3	Ossification of Posterior Longitudinal Ligament 05/2022 - 12/2019
3	Paralysis (Palsy) 05/2022 - 12/2019
3	Kyphosis 01/2022 - 11/2009
3	Disease Progression 01/2022 - 01/2017
3	Relapsing Polychondritis 01/2022 - 01/2021
3	Hematologic Neoplasms (Hematological Malignancy) 11/2021 - 09/2014
3	Necrosis 07/2021 - 07/2009
3	COVID-19 01/2021 - 08/2020
3	Intervertebral Disc Displacement (Herniated Disc) 01/2021 - 02/2007
3	Hypersensitivity (Allergy) 11/2019 - 01/2014
3	Philadelphia Chromosome 02/2019 - 01/2016
3	Contusions 06/2015 - 05/2012
2	Oral Ulcer (Mouth Ulcer) 10/2022 - 07/2021
2	Wounds and Injuries (Trauma) 10/2022 - 02/2007
2	Polyneuropathies (Polyneuropathy) 08/2022 - 01/2015
2	Hematoma 05/2022 - 09/2012
2	Respiratory Insufficiency (Respiratory Failure) 05/2022 - 09/2017
2	Systemic Scleroderma (Systemic Sclerosis) 03/2022 - 01/2022
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2022 - 01/2021
2	Ischemia 01/2022 - 07/2009
2	VEXAS syndrome 01/2022 - 11/2021
2	Rheumatic Diseases (Rheumatism) 01/2022 - 01/2021
2	Vitamin D Deficiency 01/2022 - 01/2013
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2021 - 01/2020
2	Diffuse Idiopathic Skeletal Hyperostosis 10/2021 - 01/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 08/2022 - 05/2002
5	CytokinesIBA 10/2020 - 01/2013
5	Interleukin-6 (Interleukin 6)IBA 12/2014 - 12/2004
5	Nerve Growth Factors (Neurotrophins)IBA 10/2013 - 08/2003
4	GlucocorticoidsIBA 01/2022 - 03/2008
4	Prednisolone (Predate)FDA LinkGeneric 12/2021 - 11/2009
4	Tyrosine Kinase InhibitorsIBA 01/2021 - 08/2003
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2011 - 09/2008
3	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2016
3	EnzymesIBA 01/2022 - 09/2014
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 04/2008
3	Biological ProductsIBA 01/2021 - 09/2009
3	Biomarkers (Surrogate Marker)IBA 09/2020 - 01/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2019 - 02/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2019 - 09/2009
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2012 - 04/2007
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 07/2009 - 07/2004
3	Substance PIBA 09/2008 - 02/2005
2	apremilastIBA 10/2022 - 07/2021
2	InterferonsIBA 08/2022 - 11/2018
2	C-Reactive ProteinIBA 08/2022 - 08/2020
2	Inosine Triphosphate (ITP)IBA 02/2022 - 01/2021
2	VaccinesIBA 02/2022 - 02/2021
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 07/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 06/2002
2	tocilizumab (atlizumab)FDA Link 01/2022 - 11/2021
2	Vitamin D FDA LinkGeneric 01/2022 - 11/2016
2	Pregabalin (Lyrica)FDA Link 01/2022 - 09/2019
2	AntibodiesIBA 12/2021 - 01/2015
2	Fluconazole (Zonal)FDA LinkGeneric 11/2021 - 05/2019
2	Interferon Type IIBA 11/2021 - 10/2018
2	AutoantigensIBA 11/2021 - 01/2020
2	Immunosuppressive Agents (Immunosuppressants)IBA 07/2021 - 01/2021
2	DiamondIBA 01/2021 - 08/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 05/2002
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2020 - 06/2002
2	Dihydrotachysterol (AT 10)IBA 09/2020 - 01/2009
2	Serum AlbuminIBA 08/2020 - 01/2018

Therapy/Procedure

12	Therapeutics 01/2022 - 09/2009
10	Decompression 01/2022 - 05/2009
8	Hematopoietic Stem Cell Transplantation 12/2022 - 01/2016
6	Transplantation 10/2022 - 02/2012
5	Hip Replacement Arthroplasty (Total Hip Replacement) 07/2013 - 05/2010
4	Drug Therapy (Chemotherapy) 01/2022 - 06/2018
4	Laminoplasty 01/2022 - 09/2009
3	Conservative Treatment 10/2022 - 01/2017
3	Cell Transplantation 10/2022 - 02/2019
3	Operative Surgical Procedures 01/2021 - 09/2009
3	Stem Cell Transplantation 01/2019 - 02/2012
2	Reoperation 01/2022 - 10/2021
2	Salvage Therapy 01/2022 - 02/2019
2	Foraminotomy 01/2022 - 09/2009
2	Radiotherapy 09/2020 - 07/2009